Boule Diagnostics AB (publ) (STO:BOUL)

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Diagnostics	372.70M	-	-	-	-
OEM Clinical Diagnostic Solutions	134.60M	-	-	-	-
Other	-17.70M	-	-	-	-
Development, Manufacturing and Sales of Blood Analysis Products	-	558.46M	571.33M	548.09M	463.34M
Development, Manufacturing and Sales of Blood Analysis Products Growth	-	-2.25%	4.24%	18.29%	15.70%
Total	489.60M	558.46M	571.33M	548.09M	463.34M
Total Growth	-12.33%	-2.25%	4.24%	18.29%	15.70%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
USA	170.70M	196.79M	199.19M	189.85M	152.56M
USA Growth	-13.26%	-1.20%	4.92%	24.44%	18.87%
Asia	123.60M	152.84M	169.33M	150.72M	121.33M
Asia Growth	-19.13%	-9.74%	12.35%	24.22%	16.69%
Eastern Europe	52.50M	62.12M	38.57M	62.26M	61.14M
Eastern Europe Growth	-15.49%	61.05%	-38.05%	1.84%	10.00%
Latin America	29.00M	41.32M	51.51M	44.98M	37.71M
Latin America Growth	-29.81%	-19.78%	14.52%	19.29%	14.85%
Western Europe	66.20M	49.37M	50.75M	39.62M	32.20M
Western Europe Growth	34.09%	-2.72%	28.08%	23.06%	-10.44%
Africa/Middle East	47.60M	56.02M	61.98M	60.66M	-
Africa/Middle East Growth	-15.04%	-9.60%	2.17%	-	-
Africa	-	-	-	-	33.85M
Africa Growth	-	-	-	-	83.90%
The Middle East	-	-	-	-	24.57M
The Middle East Growth	-	-	-	-	-3.18%
Total	489.60M	558.46M	571.33M	548.09M	463.34M
Total Growth	-12.33%	-2.25%	4.24%	18.29%	15.70%

Source: S&P Global Market Intelligence.